Literature DB >> 27002809

Ascorbic acid intake and oxalate synthesis.

John Knight1, Kumudu Madduma-Liyanage1, James A Mobley2, Dean G Assimos1, Ross P Holmes3.   

Abstract

In humans, approximately 60 mg of ascorbic acid (AA) breaks down in the body each day and has to be replaced by a dietary intake of 70 mg in women and 90 mg in men to maintain optimal health and AA homeostasis. The breakdown of AA is non-enzymatic and results in oxalate formation. The exact amount of oxalate formed has been difficult to ascertain primarily due to the limited availability of healthy human tissue for such research and the difficulty in measuring AA and its breakdown products. The breakdown of 60 mg of AA to oxalate could potentially result in the formation of up to 30 mg oxalate per day. This exceeds our estimates of the endogenous production of 10-25 mg oxalate per day, indicating that degradative pathways that do not form oxalate exist. In this review, we examine what is known about the pathways of AA metabolism and how oxalate forms. We further identify how gaps in our knowledge may be filled to more precisely determine the contribution of AA breakdown to oxalate production in humans. The use of stable isotopes of AA to directly assess the conversion of vitamin to oxalate should help fill this void.

Entities:  

Keywords:  Ascorbate; Metabolism; Oxalate; Vitamin C

Mesh:

Substances:

Year:  2016        PMID: 27002809      PMCID: PMC4946963          DOI: 10.1007/s00240-016-0868-7

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  59 in total

1.  Estimation of the oxalate content of foods and daily oxalate intake.

Authors:  R P Holmes; M Kennedy
Journal:  Kidney Int       Date:  2000-04       Impact factor: 10.612

Review 2.  Dietary oxalate and its intestinal absorption.

Authors:  R P Holmes; H O Goodman; D G Assimos
Journal:  Scanning Microsc       Date:  1995

3.  Ascorbic acid supplements and kidney stone incidence among men: a prospective study.

Authors:  Laura D K Thomas; Carl-Gustaf Elinder; Hans-Göran Tiselius; Alicja Wolk; Agneta Akesson
Journal:  JAMA Intern Med       Date:  2013-03-11       Impact factor: 21.873

Review 4.  Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome?

Authors:  Saeed R Khan
Journal:  Urol Res       Date:  2012-01-04

5.  Hydroxyproline ingestion and urinary oxalate and glycolate excretion.

Authors:  J Knight; J Jiang; D G Assimos; R P Holmes
Journal:  Kidney Int       Date:  2006-10-04       Impact factor: 10.612

6.  Urinary oxalate excretion increases in home parenteral nutrition patients on a higher intravenous ascorbic acid dose.

Authors:  Lourdes Peña de la Vega; John C Lieske; Dawn Milliner; Janelle Gonyea; Darlene G Kelly
Journal:  JPEN J Parenter Enteral Nutr       Date:  2004 Nov-Dec       Impact factor: 4.016

7.  Secondary oxalosis: a cause of delayed recovery of renal function in the setting of acute renal failure.

Authors:  A M Alkhunaizi; L Chan
Journal:  J Am Soc Nephrol       Date:  1996-11       Impact factor: 10.121

8.  Reference range for gastrointestinal oxalate absorption measured with a standardized [13C2]oxalate absorption test.

Authors:  Gerd E von Unruh; Susanne Voss; Tilman Sauerbruch; Albrecht Hesse
Journal:  J Urol       Date:  2003-02       Impact factor: 7.450

9.  Intestinal dehydroascorbic acid (DHA) transport mediated by the facilitative sugar transporters, GLUT2 and GLUT8.

Authors:  Christopher P Corpe; Peter Eck; Jin Wang; Hadi Al-Hasani; Mark Levine
Journal:  J Biol Chem       Date:  2013-02-08       Impact factor: 5.157

Review 10.  Molecular basis for the deficiency in humans of gulonolactone oxidase, a key enzyme for ascorbic acid biosynthesis.

Authors:  M Nishikimi; K Yagi
Journal:  Am J Clin Nutr       Date:  1991-12       Impact factor: 7.045

View more
  24 in total

1.  Benefits of Ascorbic Acid in Association with Low-Dose Benznidazole in Treatment of Chagas Disease.

Authors:  Maiara Voltarelli Providello; Zumira Aparecida Carneiro; Gisele Bulhões Portapilla; Gabriel Tavares do Vale; Ricardo Souza Camargo; Carlos Renato Tirapelli; Sérgio de Albuquerque
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

2.  The association of sleep with metabolic pathways and metabolites: evidence from the Dietary Approaches to Stop Hypertension (DASH)-sodium feeding study.

Authors:  Vanessa L Z Gordon-Dseagu; Andriy Derkach; Qian Xiao; Ishmael Williams; Joshua Sampson; Rachael Z Stolzenberg-Solomon
Journal:  Metabolomics       Date:  2019-03-16       Impact factor: 4.290

3.  Oxalosis Associated With High-Dose Vitamin C Ingestion in a Peritoneal Dialysis Patient.

Authors:  Matthew R D'Costa; Nelson S Winkler; Dawn S Milliner; Suzanne M Norby; LaTonya J Hickson; John C Lieske
Journal:  Am J Kidney Dis       Date:  2019-03-22       Impact factor: 8.860

4.  Hydroxyproline Metabolism and Oxalate Synthesis in Primary Hyperoxaluria.

Authors:  Sonia Fargue; Dawn S Milliner; John Knight; Julie B Olson; W Todd Lowther; Ross P Holmes
Journal:  J Am Soc Nephrol       Date:  2018-03-27       Impact factor: 10.121

5.  The effects of the inactivation of Hydroxyproline dehydrogenase on urinary oxalate and glycolate excretion in mouse models of primary hyperoxaluria.

Authors:  Brianna Buchalski; Kyle D Wood; Anil Challa; Sonia Fargue; Ross P Holmes; W Todd Lowther; John Knight
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-12-07       Impact factor: 5.187

6.  Reduction in urinary oxalate excretion in mouse models of Primary Hyperoxaluria by RNA interference inhibition of liver lactate dehydrogenase activity.

Authors:  Kyle D Wood; Ross P Holmes; David Erbe; Abigail Liebow; Sonia Fargue; John Knight
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-05-02       Impact factor: 5.187

7.  An untargeted metabolomics study of blood pressure: findings from the Bogalusa Heart Study.

Authors:  William J He; Changwei Li; Xuenan Mi; Mengyao Shi; Xiaoying Gu; Lydia A Bazzano; Alexander C Razavi; Jovia L Nierenberg; Kirsten Dorans; Hua He; Tanika N Kelly
Journal:  J Hypertens       Date:  2020-07       Impact factor: 4.844

8.  Effect of alanine supplementation on oxalate synthesis.

Authors:  Kyle D Wood; Brian L Freeman; Mary E Killian; Win Shun Lai; Dean Assimos; John Knight; Sonia Fargue
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-09-28       Impact factor: 5.187

Review 9.  Nutrition and Kidney Stone Disease.

Authors:  Roswitha Siener
Journal:  Nutrients       Date:  2021-06-03       Impact factor: 5.717

Review 10.  Future treatments for hyperoxaluria.

Authors:  Zachary Burns; John Knight; Sonia Fargue; Ross Holmes; Dean Assimos; Kyle Wood
Journal:  Curr Opin Urol       Date:  2020-03       Impact factor: 2.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.